1. Startseite
  2. Aktien
  3. Japan
  4. Japan Exchange
  5. Sankyo Co., Ltd.
  6. News
  7. Andere Sprachen
    6417   JP3326410002

SANKYO CO., LTD.

(6417)
  Bericht
Verzögert Japan Exchange  -  08:00 17.08.2022
4010.00 JPY   +0.25%
15.08.MÄRKTE EUROPA/Aktien bauen Gewinne aus - Ölpreise stürzen ab
DJ
15.08.MÄRKTE EUROPA/Gewinne verteidigt - Ölpreise stürzen ab
DJ
15.08.Verhaltener Wochenstart an Börsen nach mauen China-Daten
RE
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über SANKYO CO., LTD.
15.08.Las acciones europeas suben impulsadas por sectores defensivos tras débiles datos de Ch..
15.08.Point marchés-Les actions freinées par la nervosité sur la Chine, le pétrole baisse
15.08.Wall Street attendue dans le rouge, la Chine inquiète
15.08.Point marchés-Wall Street attendue dans le rouge, la Chine inquiète
15.08.Nikkei 225 Up 1.1% on Wall Street Cues, Earnings Season
15.08.AstraZeneca, Daiichi Sankyo Say Their Breast Cancer Drug Delayed Disease Progression in..
15.08.FTSE 100 inches higher as AstraZeneca counters China worries
15.08.Las bolsas europeas suben, mientras los débiles datos de China avivan la preocupación
15.08.European shares edge higher; weak China data stokes worries
15.08.ASTRAZENECA : des résultats positifs dans le cancer du sein
15.08.Japan Index Rallies on Upbeat Economic Reports; Daiichi Sankyo Soars 14% on Legal Victo..
15.08.AstraZeneca-Daiichi's breast cancer drug improves survival in study
15.08.Enhertu Significantly Delayed Breast Cancer Progression in Trial, AstraZeneca Says
15.08.AstraZeneca's Enhertu Prolongs Progression-free Survival in Late-stage Breast Cancer St..
15.08.Daiichi Sankyo Shares Gain After It Wins Dispute Over Cancer Drug Technology
12.08.Seagen Loses Arbitration Against Daiichi Sankyo; Sees No Impact on Existing Business
12.08.Seagen loses arbitration against Daiichi Sankyo over drug technology
12.08.Seagen loses arbitration ruling against Daiichi Sankyo
12.08.Guardant Health Says FDA Approved Liquid Biopsy Test as Companion Diagnostic for Lung C..
12.08.ASTRAZENECA : la FDA étend son approbation d'Enhertu
12.08.AstraZeneca, Daiichi Sankyo Receive FDA Approval for Lung Cancer Drug
12.08.AstraZeneca's Lung Cancer Drug Secures US FDA's Nod
12.08.AstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer Treatment
10.08.Japan's Nikkei falls as chip shares track U.S. peers lower
09.08.ASTRAZENECA : résultats prometteurs dans le cancer du poumon
09.08.AstraZeneca Reports Promising Data From Lung Cancer Trial
09.08.AstraZeneca JV's Non-small Cell Lung Cancer Drug Show Favorable Results On Trial
08.08.ASTRAZENECA : l'approbation d'Enhertu étendue aux Etats-Unis
08.08.AstraZeneca's Enhertu Breast Cancer Treatment Approved for Use in US
08.08.AstraZeneca's Breast Cancer Drug Wins US FDA's First-in-class Approval
05.08.Enhertu, de AstraZeneca, obtiene una esperada autorización para el cáncer de mama en EE..
05.08.AstraZeneca's Enhertu wins keenly-anticipated U.S. breast cancer nod
04.08.Sankyo Co., Ltd. Provides Dividend Guidance for Second Quarter and for Year Ended March..
04.08.Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023
01.08.Daiichi Sankyo's Fiscal Q1 Attributable Profit Declines 47% on Higher Expenses
27.07.Daiichi Sankyo Concludes Restricted Share-based Compensation
26.07.MODA : Leonard Paris entra nell'orbita di Sankyo Seiko (MFF)
25.07.ASTRAZENECA : a obtenu un examen prioritaire aux États-Unis
25.07.Sankyo Seiko to purchase French luxury fashion house Leonard
25.07.AstraZeneca, Daiichi Sankyo's Enhertu Awarded Priority Review in the US to Treat Breast..
25.07.AstraZeneca's Enhertu Treatment Granted Priority Review Status by FDA
21.07.SANKYO : Notice concerning Determination of Certain Details of the Issuance of Stock Compe..
19.07.European Commission Approves AstraZeneca, Daiichi Sankyo's Enhertu for Use in EU
19.07.Nikkei 225 Up 0.7% on Federal Reserve Outlook
19.07.ASTRAZENECA : indication élargie pour Enhertu dans l'UE
19.07.AstraZeneca Says Metastatic Breast Cancer Treatment Enhertu Approved in EU
11.07.Nikkei 225 Up 1.1% on Election Win By Ruling Bloc, Softer Yen
06.07.Sankyo to Grant Stock Compensation-type Options
05.07.SANKYO : Notice concerning Issuance of Stock Compensation-type Stock Options (Subscription..
27.06.AstraZeneca Partner Daiichi Sankyo Says EMA's Committee Backs Approval of Trastuzumab D..
27.06.ASTRAZENECA : avis favorable du CHMP pour Enhertu
27.06.AstraZeneca's Lynparza, Enhertu Win EU Panel's Backing for Approval in Breast Cancer
27.06.AstraZeneca-Daiichi Sankyo Enhertu Breast Cancer Drug Is Recommended for EU Approval
22.06.European Medicines Agency Validates AstraZeneca-Daiichi Sankyo Application for Breast C..
22.06.ASTRAZENECA : l'EMA accepte un dossier dans le cancer du sein
22.06.AstraZeneca Partner Daiichi Sankyo Says Type II Variation Application for Breast Cancer..
14.06.Nikkei 225 Down 1.3% on Central Bank Outlooks, Wall Street Cues
07.06.Japan's Nikkei hits over 2-month high on automakers boost
06.06.MARCHÉS : regain de confiance après la levée de restrictions anti-Covid en Chine
06.06.Tokyo a profité du yen faible, Hong Kong salue la levée des restrictions à Pékin
06.06.AstraZeneca's Enhertu Delays Breast Cancer Progression, Death in Late-stage Study
06.06.Tokyo en repli après le rapport sur l'emploi américain
01.06.Nikkei 225 Up 0.7% As Softer Yen Boost Export Issues
01.06.Japanese shares rise as automakers rally after report forecasts positive earnings
01.06.Japanese shares rise led by automakers
25.05.Nikkei 225 Slips 0.3% on Stronger Yen
25.05.Japanese shares end lower on Wall Street weakness
12.05.Sankyo Co., Ltd. Provides Dividend Guidance for Second Quarter and for Year Ended March..
12.05.Sankyo Co., Ltd. Announces Dividend for the Year Ended March 31, 2022, Payable on June ..
12.05.Sankyo Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2023
05.05.AstraZeneca, Daiichi Sankyo Say US FDA Clears Enhertu to Treat Breast Cancer; AstraZene..
05.05.AstraZeneca, Daiichi's Breast Cancer Treatment Wins US Approval
05.05.AstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer Treatment
04.05.Sankyo Acquires Own Shares for Nearly $6 Million in April
02.05.SANKYO : Notice concerning Status and Completion of Repurchase of the Company's Own Shares
1  2  3  4  5  6Weiter
Anstehende Termine für SANKYO CO., LTD.